| Literature DB >> 29651248 |
Sotirios I Sinis1, Chrissi Hatzoglou1,2, Konstantinos I Gourgoulianis2, Sotirios G Zarogiannis1,2.
Abstract
Nanoparticles have great potential for numerous applications due to their unique physicochemical properties. However, concerns have been raised that they may induce deleterious effects on biological systems. There is accumulating evidence that, like asbestos, inhaled nanomaterials of >5 μm and high aspect ratio (3:1), particularly rod-like carbon nanotubes, may inflict pleural disease including mesothelioma. Additionally, a recent set of case reports suggests that inhalation of polyacrylate/nanosilica could in part be associated with inflammation and fibrosis of the pleura of factory workers. However, the adverse outcomes of nanoparticle exposure to mesothelial tissues are still largely unexplored. In that context, the present review aims to provide an overview of the relevant pathophysiological implications involving toxicological studies describing effects of engineered nanoparticles on mesothelial cells and membranes. In vitro studies primarily emphasize on simulating cellular uptake and toxicity of nanotubes on benign or malignant cell lines. On the other hand, in vivo studies focus on illustrating endpoints of serosal pathology in rodent animal models. From a molecular aspect, some nanoparticle categories are shown to be cytotoxic and genotoxic after acute treatment, whereas chronic incubation may lead to malignant-like transformation. At an organism level, a number of fibrous shaped nanotubes are related with features of chronic inflammation and MWCNT-7 is the only type to consistently inflict mesothelioma.Entities:
Keywords: environmental pollutants; mesothelium; nanoparticles; nanotoxicology; nanotubes; peritoneum; pleura
Year: 2018 PMID: 29651248 PMCID: PMC5884948 DOI: 10.3389/fphys.2018.00295
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Overview of the mechanisms of cellular uptake and toxicity of CNTs in mesothelial cells.
Figure 2Overview of the route of entry of CNTs into the pleural cavity and the associated pathophysiological events.
In vitro studies describing CNT toxicity on mesothelial cells (minute = min, hour = h, month = mo) *transferrin receptor 1.
| Pacurari et al., | SWCNTs (0.8–2.0 nm) | Normal mesothelial/Malignant mesothelial | 25 μg/cm2 for 120 min 25 μg/cm2 for 1, 2, or 4 h 0, 25, 75, 125 μg/cm2 for 30 or 60 min | ROS mediated p38, ERK upregulation AP-1, NF-kB activation Akt upregulation |
| Tabet et al., | MWCNTs (12 nm, 0.1–13 μm) | MeT5A | 100 μg/ml 24 h | Dispersion media affects agglomerate number/No internalization/disruption of mitochondrial metabolism |
| Haniu et al., | MWCNTs (150 nm, 8 μm) | MESO-1 | 10 μg/mL for 24 h | Tubes in gelatin and DPPC decreased viability by 38 and 83% resp./tubes in CMC neither entered nor damaged the cells |
| Haniu et al., | MWCNTs (150 nm, 8 μm) | MESO-1 | 1, 10 μg/mL for 24 h 50 mg/L | Endocytosis/vacuole penetration Less that 50% viability, 50% increase in permeability |
| Nagai et al., | MWCNTs
2 to 20 nm, 3 μm 50 nm, 4 μm 50 nm, 10 μm 115 nm, 8 μm 145 nm, 6 μm | MeT5A, HPMCs | 5 μg/cm2, 24 h incubation 5 μg/cm2, 3 h incubation | Inverse correlation between diameter and toxicity/no active internalization Thin and rigid able to penetrate membranes |
| Lindberg et al., | SWCNTs (<2 nm, 1–5 μm), MWCNTs (10–30 nm, 1–2 μm) | MeT5A | 5–80 μg/cm2 for 24, 48, and 72 h 40 μg/cm2 for 24 and 48 h 80 μg/cm2 for 48 h 1, 5, 10, and 40 μg/cm2 for 48 h | Internalization/viability reduction SWCNTs inflict DNA damage SWCNTs and MWCNs inflict DNA damage SWCNTs induce oxidative stress |
| Lohcharoenkal et al., | SWCNTs (1–4 nm, 1–4 μm), MWCNTs (81 nm, 8.19 μm) | MeT5A | 0.02 μg/cm for 4 mo | Increased migration, proliferation/Increased MMP-2, PLAU, STAT-3, AKT1, VEGFA expression |
| Haniu et al., | MWCNTs
15 nm, 3 μm 80 nm, 10 μm 150 nm,8 μm | MeT5A, HPMCs | 10 mg/ml for 24 h 10 mg/ml for 1 h 50 mg/ml for 24 h | Internalization of all CNT/150 nm resulted in most permeable membrane (29%) 15 nm resulted in greatest oxidative potential 150 nm or 80 nm induced autophagy |
| Lohcharoenkal et al., | SWCNTs | MeT5A, LP9 | 0.02, 0.06, 0.2 μg/cm2 for 2 mo | Increased cell growth of MeT5A and invasiveness of both cell lines/Activation of H-Ras-ERK signaling/ERK mediated cortactin upregulation/Integrin AV upregulation |
| Zhang et al., | SWCNTs (0.38 μm, 1.42 μm) | MeT5A | 0.02 μg/cm for 4 mo | Increased migration, spindled morphology after chronic exposure |
| Wang et al., | MWCNTs (2–20 nm tangled, 50 nm MWCNT-7, 115 nm, 145 nm) | RPMCs | 10 μg/cm2 | Hemoglobin or transferrin coated MWCNT-7 are internalized via TR1*, increase catalytic iron content and induce aggravated genotoxicity |
| Yu et al., | MWCNT (110–170 nm, 5–9 μm) | MeT5A | 0 to 40 μg/mL for 24 h | lysosomes contain MWCNTs/oxidative stress activates ERK1,2 that induces SOD-2 upregulation |
| Ju et al., | MWCNT (110–170 nm, 5–9 μm) | MeT5A | 10 mg/cm2 for 3 mo | Increased proliferation, invasion/DNA lesions/Altered expression of Annexins 1, 2, 5, 6 |
CNT associated serosal toxicity after respiratory system exposure (day = d, week = w, month = mo, year = yr).
| Poland et al., | MWCNT 20–30 nm, 0.5–2 μm 15 nm, 1–5 μm 15 nm, 5–20 μm 40–50 nm,13 μm 20–100 nm, max. 56 μm | C57BL/6J mice (intrapleural injection) | 5 mg for 24 h, 7 d, 4 w, 12 w, and 24 w | Inflammatory response to long CNTs (13 μm, max 56 μm)/lesions characterized by inflammation, mesothelial proliferation, fibrosis and CNT aggregates at 24 w |
| Mercer et al., | MWCNT (49 nm, 3.9 μm) | C57BL/6J mice (pharyngeal aspiration) | 10, 20, 40 and 80 mg per lung up to 56 d | 0.6% of MWCNT burden reach the subpleura/80 mg resulted in increased penetrations at days 1, 28, and 56 |
| Porter et al., | MWCNT (49 nm, 3.86 μm) | C57BL/6J mice (pharyngeal aspiration) | 80 mg up to 56 d | MWCNTs penetrated the pleura/Pleuritis in one mouse exposed to 10 g, all mice exposed to 20 or 40 g, and three mice exposed to 80 g |
| Xu et al., | MWCNT-7 MWCNT-N | F344 rats (intrapulmonary spraying) | 5 sprayings of 250 mg for 9 d | Pleural deposition/Hyperplasic proliferative lesions of the visceral mesothelium |
| Mercer et al., | MWCNT | C57BL/6J mice (inhalation) | 5 mg/m3 for 5 h/d for 12 d | At 336 d MWCNT were found in chest wall and diaphragm |
| Murphy et al., | MWCNT (165 nm, 36 μm) | F344 rats (intrapulmonary spraying) | 25 μg for 6 w | Pleural penetrations by few nanotubes/lesions with foreign body giant cells, granulocytes and collagen |
| Porter et al., | MWCNT | C57BL/6J mice (inhalation) | 10 mg/m3, 5 h/d for 2, 4, 8 or 12 d | MWCNTs penetrated the pleura of two mice at 12 days post-exposure |
| Xu et al., | MWCNT 150 nm, 8 μm 15 nm, 3 μm | C57BL/6J mice (intrapulmonary spraying) | 1.625 mg for 24 w | Long CNT in pleural cavity/Long CNT more potent in inducing hyperplasic proliferative or fibrotic foci of the parietal pleura |
| Fujita et al., | SWCNT-MWCNT (0.5 and 1.8 μm resp.) | Wistar rats (intratracheal instillation) | 0.15 or 1.5 mg/kg over 90 d | Short MWCNT migrate to the pleura more efficiently and induce greater inflammation and proliferation compared to short SWCNT |
| Kasai et al., | MWCNT-7 (90.7 nm, 5.7 μm) | F344/DuCrlCrlj rats (inhalation) | 0, 0.2, 1 and 5 mg/m3 for 62 times in a 13 week period | Visceral pleural and subpleural inflammation/CNT located in the diaphragm |
| Kasai et al., | MWCNT-7 (90.7 nm, 5.7 μm) | F344/DuCrlCrlj rats (inhalation) | 0.02, 0.2, or 2 mg/m3 for 6 h/d, 5 d/w up to 104 w | With increasing dose, pleural penetrations became more frequent/Hyperplasic lesions at 2 mg/m3 |
| Suzui et al., | MWCNT-N | F344/Crj rats (pharyngeal aspiration) | 1 mg over 14 d (109 w duration) | Benign proliferative lesions and increased mesothelioma incidence |
Studies of intraperitoneal injection of CNTs (day = d, month = mo, year = yr).
| Takagi et al., | MWCNT-7 | p53(+/–) C57BI/6 mice | 3 mg up to 180 d | Fibrogranulomatous lesions/Atypical hyperplasia/Mesothelioma |
| Muller et al., | MWCNT (11.3 nm, 0.7 μm) | Wistar rats | 2 or 20 mg (24 month follow up period) | Limited inflammation and granuloma formation around CNTs |
| Sakamoto et al., | MWCNT-7 | F344 rats | 1 mg/kg of weight | Mesothelial hyperplasia/Mesothelioma in 6 out of 7 after 37 to 40 w |
| Nagai et al., | MWCNT-7 (50 nm) | F344-Brown Norway F1 hybrids | 1 and 10 mg for 1 yr | Thin and rigid CNTs have greater mesothelial carcinogenicity/Typical lesions characterized by granulomas, fibrosis, iron deposition, mesothelial hyperplasia/tumor suppressor Cdkn2a/2b deletions |
| Osmond-McLeod et al., | MWCNT (60 nm, 12.4 μm) | C57BI/6 mice | 50 mg for 24 h and 7d | Pristine inflicted inflammation at 24 h up to 7 d and fibrosis at 7 d/Degraded CNTlong1 was less inflammogenic and fibrogenic |
| Takagi et al., | MWCNT-7 (90 nm, 2 μm) | p53(+/–) C57BI/6 mice | 3, 30, 30 mg for 1 yr | Concentration dependent mesothelioma/Hyperplasic and fibrotic lesions with granuloma and monocytes |
| Nagai et al., | MWCNT (15 nm tangled) | F344-Brown Norway F1 hybrids | 10 mg for 3 yr | Absence of mesothelioma/Granuloma without iron deposition |
| Rittinghausen et al., | MWCNTs 62 nm, 2.13 μm 37 nm, 2.53 μm 85 nm, 2.72 μm 40 nm, 4.18 μm | Wistar rats | 0.2 and 1 mg 0.6 and 3 mg 0.08 and 0.4 mg 0.05 and 0.25 mg, resp. for 24 mo | Inverse correlation between curvature and mesothelioma frequency or progression/Typical lesions and peritoneal adhesions |
| Toyokuni et al., | SWCNT (3.83 nm/4.3 nm) | Wistar rats | 0.1, 0.3, 1, 3, 10 mg for 4 w | SWCNTs caused minimal inflammation/Aggregates of the nanomaterial in the peritoneal cavity |
| Huaux et al., | MWCNT-7 (7.1 μm, 2.8 μm) | Wistar rats | 6 mg for 12 mo 2 mg for 30 d | “MWCNT-7 induced mesothelioma is facilitated by an early fiber specific accumulation of immunosuppressive monocytes” |